CIPHER PHARMACEUTICALS INC
Manufacturer / marketing-authorisation holder
CIPHER PHARMACEUTICALS INC — 15 products across 2 markets, 8 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
CIPHER PHARMACEUTICALS INC — 15 productos en 2 mercados, 8 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
CIPHER PHARMACEUTICALS INC —— 共 15 个产品，覆盖 2 个市场、8 个品牌名。产品按国家分组；品牌名链到品牌页，成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」，不一定是生产工厂。
15 products · 2 markets · 8 brand names
15 productos · 2 mercados · 8 marcas
15 个产品 · 2 个市场 · 8 个品牌名
Products by country
US
Source: api.fda.gov
CA
Source: health-products.canada.ca
| Brand | Active ingredient(s) | Form |
|---|---|---|
| ACTIKERALL | 氟尿嘧啶 + 水杨酸 | liquid |
| AGGRASTAT | 盐酸替罗非班 | liquid |
| BRINAVESS | 维纳卡兰 | liquid |
| DURELA | 曲马多 | capsule |
| DURELA | 曲马多 | capsule |
| DURELA | 曲马多 | capsule |
| EPURIS | 异维A酸 | capsule |
| EPURIS | 异维A酸 | capsule |
| EPURIS | 异维A酸 | capsule |
| EPURIS | 异维A酸 | capsule |
| FENOMAX | 非诺贝特 | capsule |
| FENOMAX | 非诺贝特 | capsule |
| VANIQA | Eflornithine | topical |